USPTO serial 97576507
MEDFUSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MORAN, CAROLINE L
- Law office
- TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MEDFUSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine H. Stockell
Catherine H. Stockell FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business and management consulting for medical and healthcare providers and related businesses; Business and management consulting for the pharmaceutical industry; Consulting in the fields of healthcare operations management, hospital operations management, and pharmaceuticals; Consulting services in the field of patient relationship management for healthcare providers; Consulting services in the cost management of health care; Business management and consulting services for the health care industry in the fields of strategic business objectives, reducing costs, increasing revenue, and advancing population health; Business consulting for the medical and healthcare industry, namely, the collection, reporting and analysis of healthcare quality data for networks of health care providers for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting in the field of clinical trials, namely, compilation of computerized databases in the field of clinical trials for business purposes | ACTIVE | May 20, 2022 |
| 042 | Providing information about medical research; Compiling data for research purposes in the field of healthcare, medical science, medical consultancy, and pharmaceuticals; Research services, namely, scientific research conducted using databases; Providing medical and scientific data and research information in the field of clinical trials; Providing on-line non-downloadable computer search engine; Providing on-line non-downloadable search engine and analytical tools for conducting research in the fields of health, medicine, pharmaceuticals, physician demographics, physician mapping, and de-identified patient claims data; Providing on-line non-downloadable computer software and software tools for database management; Providing on-line non-downloadable software and software tools for storing, accessing, and sharing patient medical, health and claims data; Providing on-line non-downloadable database of physician demographics, namely, age, gender, specialty, geographic locations, practice affiliations, education, publications, speaking engagements, and other thought leadership activities; Providing on-line non-downloadable database of de-identified patient claims data, including pharmacy claims, hospital claims, long-term care claims, and ambulatory claims; Providing on-line non-downloadable software and software tools for conducting identifying clinical research participants and conducting clinical research in the field of medicine, healthcare, and pharmaceuticals; Providing on-line non-downloadable computer software and software tools for data collection and storage and providing data analytics and data insights; Providing on-line non-downloadable software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing on-line non-downloadable software for conducting research in the fields of medicine, pharmaceuticals, disease management and population health; Software-as-a-service (SAAS) featuring software and software tools for data collection and storage and providing data analytics and data insights; Platform-as-a-service (PAAS) featuring software and software tools for data collection and storage and providing data analytics and data insights; Providing software as a service (SAAS) services featuring software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing platform as a service (PAAS) services featuring software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing software as a service (SAAS) services featuring software for providing users with counseling and monitoring in the fields of medicine, pharmaceuticals, disease management and population health; Providing platform as a service (PAAS) services featuring software for providing users with counseling and monitoring in the fields of medicine, pharmaceuticals, disease management and population health | ACTIVE | May 20, 2022 |
| 044 | Providing medical information and pharmaceutical information; Providing medical information and data through the use of a data storage and retrieval system; Providing an internet-based database that provides information in the field of medicine, healthcare, pharmaceuticals, healthcare providers, patient claims, and medical information; Providing an internet-based database of de-identified patient claims data, including pharmacy claims, hospital claims, long-term care claims and ambulatory claims; Providing an internet-based database of physician demographics, namely, age, gender, specialty, geographic locations, practice affiliations, education, publications, speaking engagements, and other thought leadership activities | ACTIVE | May 20, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 3, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 3, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 21, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 21, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 21, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2022 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 6, 2022 | NWAP | NEW APPLICATION ENTERED | — |